COMMUNIQUÉS West-GlobeNewswire

-
PolTREG Establishes U.S. Subsidiary Immuthera to Advance International Development Strategy
13/06/2025 -
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 23 - 2025
13/06/2025 -
IPSEN - Buy-back programme - Art 5 of MAR - Week 23 - 2025
13/06/2025 -
Sunset Social Club Opens as West Hollywood’s First Luxury Cannabis Lounge for Members Only
13/06/2025 -
Biomea Fusion Presents Updated Preliminary Clinical Data for Covalent FLT3 Inhibitor BMF-500 in Relapsed or Refractory Acute Leukemia at EHA 2025
13/06/2025 -
ORLADEYO® (berotralstat) Approved in Colombia
13/06/2025 -
Tonix Pharmaceuticals Announces Appointment of Commercial Industry Veteran, James “Jim” Hunter, to Board of Directors
13/06/2025 -
Fractyl Health to Present New Preclinical Data from its Rejuva® Smart GLP-1™ Pancreatic Gene Therapy Platform at the American Diabetes Association's 85th Scientific Sessions
13/06/2025 -
Arvinas Presents Preclinical Data for PROTAC BCL6 Degrader, ARV-393, at the European Hematology Association 2025 Congress
13/06/2025 -
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
13/06/2025 -
Altimmune Announces Multiple Presentations at Upcoming American Diabetes Association’s Scientific Sessions
13/06/2025 -
Sensei Biotherapeutics Announces 1-for-20 Reverse Stock Split
13/06/2025 -
BioRestorative Reports Compelling Preliminary Data for FDA-Fast-Tracked BRTX-100 – an Autologous Stem Cell Therapy to Treat Chronic Lumbar Disc Disease
13/06/2025 -
Indaptus Therapeutics, Inc. Announces Sale of $2.3 Million in Private Placement of Convertible Notes and Warrants
13/06/2025 -
Processa Pharmaceuticals to Engage Potential Partners and Investors at BIO International Convention 2025
13/06/2025 -
Grace Therapeutics to Participate in the 2025 BIO International Conference
13/06/2025 -
Panavance Therapeutics Announces Promising Misetionamide (GP-2250) Phase 1 Clinical Trial Interim Findings in Pancreatic Cancer at BIO 2025
13/06/2025 -
Medera and Novoheart Presented Breakthroughs in Human mini-Heart Platforms and Gene Therapy at ISSCR 2025
13/06/2025 -
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13/06/2025
Pages